Dario Is Our Lead Partner for Patient-Focused Empowerment1
We have selected Dario as our partner in whole-patient care, targeting patient outcomes and healthcare costs. Our collaboration lets us deploy innovative digital health solutions to a wider population of patients through Dario’s digital health platform. The platform offers personalized care, focusing on improving patient behaviors that support chronic disease management. Extending our reach through the utilization of digital healthcare solutions allows us to provide care to more patients and to focus on both therapeutic and behavioral choices, leading to a more holistic approach to patient care.1
Dario has created a next-generation, artificial intelligence (AI)-powered single digital therapeutic platform that is1,2:
• Flexible: addresses multiple conditions simultaneously
• Scalable: accommodates any size patient population
• Holistic: delivers whole-health personalized interventions
• Complementary: enhances traditional modes of healthcare delivery
With user consent, Dario gathers accurate patient data directly through smartphones and connected devices, ensuring a steady stream of both objective (glucose readings) and subjective (pain perception) information that can be used to provide personalized interventions.
The result is a customized experience that drives behavior changes through:
• Evidence-based interventions
• Intuitive, clinically proven digital tools
• High-quality software
• Coaching
Together, they help patients improve health and sustain meaningful outcomes.
Focusing on Unmet Needs
Together We Are Changing Habits and Changing Lives
To Change the Course of Chronic Disease, We Need to Help Change Patient Behavior.1
Even when chronic conditions are well-served by a portfolio of medications, they are often not well-controlled. The reason?3
The Dario App Uses Data-Driven and Personalized Behavioral Techniques That Empower People to Sustain Their Health Choices1
Integration across multiple chronic conditions supports sustainable behavioral changes, leading to empowered patients and helping drive down high-cost medical needs.1
A powerful analytics engine predicts, determines, and personalizes clinically meaningful interventions for each patient.1
24/7 support helps patients sustain new habits and behaviors between traditional doctor visits, driving improved outcomes.1
Delivering Value
Dario Is Making a Positive Impact on People, Organizations, and the Entire Healthcare System1
Dario’s app is making multiple conditions less challenging to manage—improving engagement, changing behavior, and supporting improved outcomes.1
As a customer-driven, scalable, software-based solution, Dario delivers cost-effective results.1
80% + 12-month
retention rate
Most digital health solutions see a
43% drop-off per year after the first month1
>248,000
people
choose it to make the right thing to do, the easy thing to do1
4.9/5-star
Apple App Store rating
from more than 20,000 user reviews1
Tying reimbursement to outcomes rather than provider visits offers more flexibility and value.1
Dario Evidence
Dario Has Been Generating Validated Clinical Evidence Since 2017
Since 2017, Dario has expanded from being glucose-centric to addressing multi-condition outcomes in patients with diabetes who also have hypertension and/or are overweight or obese. It has generated clinical data at every stage along the way.1
Dario continues ongoing research to validate and enhance the effectiveness of its health management solutions for multiple chronic conditions.1
Three studies in 2022 laid the foundation for using a single solution for chronic conditions that occur together and interact with each other.1
“Our deepening knowledge about the importance of a single solution approach has enormous potential to change the way people manage chronic conditions, and we are proud to share further insights with the scientific community."
Yifat Fundoiano-Hershcovitz, PhD
VP of Clinical and Scientific Affairs1
Dario Collaborations, Products, and Pipeline
Dario and Dexcom continuous glucose monitoring (CGM)
Dexcom CGM uses a small, wearable sensor to continuously measure and send glucose levels to a receiver or smart device, enabling people with diabetes to make real-time decisions about their health. With this agreement, data from Dexcom CGM can integrate directly into Dario’s metabolic solution, making it easy for people using the wearable device to benefit from Dario’s highly personalized support.4
This builds on the collaboration between Sanofi US and Dario as part of a digital ecosystem of dedicated technology partners and industry-leading digital therapeutics solutions.4
Contact Us
To learn more about how Sanofi is using digital health solutions to help improve outcomes and reduce the costs of chronic conditions, please click below or contact your Sanofi Account Director.
Intended for use with payers, formulary committees, or other similar entities for purposes of population-based drug selection, coverage, and/or reimbursement decision-making, pursuant to FD&C Act Section 502(a).
REFERENCES: 1. Data on File. DarioHealth. 2. DarioHealth Press Release. May 1, 2022. Accessed April 26, 2023. https://dariohealth.investorroom.com/2022-03-01-DarioHealth-Enters-into-Strategic-Agreement-with-Sanofi-U-S 3. American Action Forum. Understanding the social determinants of health. Published September 4, 2018. Accessed April 26, 2023. https://www.americanactionforum.org/research/understanding-the-social-determinants-of-health/ 4. DarioHealth Press Release. February 8, 2023. Accessed April 26, 2023. https://dariohealth.investorroom.com/2023-02-08-Dario-Partners-to-Integrate-Dexcom-CGM-Data